pharmaphorum
DECEMBER 15, 2020
Despite this, the role of generics can often be overlooked, however its performance during this crisis has demonstrated its crucial importance and ability to respond to a series of considerable challenges. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in.
European Pharmaceutical Review
JANUARY 30, 2024
The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
APRIL 30, 2024
The committee also recommended the biosimilar medicine Wezenla (ustekinumab) to treat of plaque psoriasis. Generic medicine Eribulin Baxter (eribulin) was also granted a positive opinion by the committee, to treat breast cancer and liposarcoma. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.
Pharmaceutical Technology
DECEMBER 15, 2022
These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.
pharmaphorum
JANUARY 13, 2022
Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report. The argument has been made that reducing or eliminating rebates could result in lower list prices, and reduce out-of-pocket expenses for patients. ” says the report.
Express Pharma
AUGUST 30, 2023
Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity. The establishment of a CPD-supporting entity hinges on fiscal resolutions.
Express Pharma
AUGUST 22, 2023
The report analyses selected companies of varying sizes that manufacture and market antibiotics – including research-based pharma companies, generic medicine manufacturers and business-to-business providers.
Expert insights. Personalized for you.
93 
Let's personalize your content